Back to search
Newly Diagnosed MYC/BCL2 Double-expressor DLBCL
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Newly Diagnosed MYC/BCL2 Double-expressor DLBCL trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Newly Diagnosed MYC/BCL2 Double-expressor DLBCL trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is a phase II clinical trial and is divided into three stages. Stage 1: Chemotherapy-free phase. All subjects will receive "Serplulimab, Chidamide,…
Tucidinostat (formerly known as chidamide) is an oral subtype-selective histone deacetylase inhibitor. This Randomized, Double-blind, Placebo-controlled Phase 3…